SS 008871
Alternative Names: SS-008871Latest Information Update: 30 Jun 2023
At a glance
- Originator Simcere Zaiming
- Class Antineoplastics; Small molecules
- Mechanism of Action DNA polymerase theta inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 14 Apr 2023 Pharmacodynamics and adverse events data from a preclinical study in cancer presented at the 114th Annual Meeting of the American Association for Cancer Research (AACR-2023)
- 10 Apr 2023 Preclinical trials in Cancer in China (unspecified route) before April 2023
- 04 Apr 2023 Pharmacokinetics and pharmacodynamics data from preclinical studies in Cancer presented at the 113th American Association of Cancer Research (AACR-I-2023)